Clinical Trials
2 trialsNCT03872388 2024-10-02
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03358017 2023-10-19
YAPPETIZER
Mario Negri Institute for Pharmacological Research
Phase 2 Completed